Related Experiment Video
Updated: May 25, 2026
05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
Targeting Dopamine in Acute Traumatic Brain Injury
James W Bales1, Anthony E Kline, Amy K Wagner
1Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA 15260, USA.
The Open Drug Discovery Journal
|February 7, 2012
Summary
Traumatic brain injury (TBI) causes secondary damage. This review explores how targeting dopamine signaling pathways may offer neuroprotection and improve functional outcomes after TBI.
Area of Science:
- Neuroscience
- Neurology
- Pharmacology
Background:
- Traumatic brain injury (TBI) involves initial mechanical damage and secondary insults like excitotoxicity, metabolic disruption, and oxidative stress.
- Current neuroprotective strategies often focus on cellular preservation, but functional deficits persist even with neuronal sparing.
- Effective TBI therapies require strategies that promote both neuronal survival and post-injury functional recovery.
Purpose of the Study:
- To review the role of dopamine in acute TBI.
- To discuss the potential of dopaminergic therapies as neuroprotective strategies for TBI.
Main Methods:
- Literature review of studies investigating dopamine's role in TBI.
- Analysis of research on dopaminergic signaling pathways in the context of neuroprotection and functional recovery.
Main Results:
- Dopamine signaling is implicated in TBI pathophysiology, influencing inflammation, oxidative stress, and cellular dysfunction.
- Dysregulation of dopamine levels (depletion or over-expression) can exacerbate TBI-induced damage.
- Targeting dopaminergic pathways presents a novel therapeutic avenue for TBI.
Conclusions:
- Dopaminergic therapies offer a promising approach for TBI treatment by potentially enhancing both neuronal survival and functional outcomes.
- Further research into modulating dopamine signaling is warranted for developing improved clinical TBI interventions.
